The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves' disease.
Yulin ZhouMengxi ZhouYicheng QiWeiqing WangXinxin ChenShu WangPublished in: Therapeutic advances in endocrinology and metabolism (2021)
Thyroid-stimulating immunoglobulin is a good predictor of relapse in patients with Graves' disease treated with anti-thyroid drugs. It might be safer to discontinue anti-thyroid drugs when thyroid-stimulating immunoglobulin and thyroid receptor antibody were both negative.
Keyphrases